Adam Elhofy, PhD, joined COUR in 2017. As Vice President (VP), Research, he is responsible for research and development (R&D) and translation of immunology from R&D to the clinic. Dr. Elhofy has more than 25 years of scientific research experience in immunology, neuroscience, and oncology, with 20 scientific publications in peer-reviewed journals.
Before joining COUR, Dr. Elhofy was the Chief Science Officer at Essential Pharmaceuticals, LLC, where he invented and patented the core technology for their Cell-Ess line of products, which can be used in a broad range of applications, including, but not limited to, bioproduction and primary research. He was also a Principal Investigator at a nanoparticle spin out from Argonne National Laboratories to treat skin-related autoimmune diseases. Dr. Elhofy was a Research Associate Professor at Northwestern Medical School, where he was funded with 2 multiple sclerosis training grants.
Dr. Elhofy holds a doctorate in immunology from the University of North Carolina at Charlotte, where his research won him the award of the top 5 trainee scientists by the American Association of Immunologists. He also earned a master of business administration in finance, strategy, and biotech from Northwestern University’s Kellogg School of Management and holds a bachelor’s degree in biology and political philosophy from the University of Maryland Baltimore County.